Neuromodulation and Medical Device Investors
Twelve additional early-stage investors that have an interest and/or history of investing in neuromodulation and medical devices have been provided within the enclosed spreadsheet.
Overview of Findings
- Twelve additional venture capital, private equity and corporate investing arms with a history of participating in early-stage investments for neuromodulation and medical devices have been provided within the enclosed spreadsheet.
- Notably, all twelve of the identified investors have an established track record of investing in both neuromodulation and medical device startups.
- Meanwhile, the selected investor organizations vary significantly in terms of their investment mandate, from micro venture capital funds that specialize in early-stage healthcare investments to firms that make deals across a broad array of industries and throughout the startup lifecycle.